Recent studies have shown that the CFTR modulator elexacaftor/tezacaftor/ivacaftor (ETI) can enhance and restore exocrine pancreatic function in children with CF, as evidenced by changes in FE-1 levels (9–12). The gene discussed is CFTR; the disease is cystic fibrosis.